4/2
07:27 am
ontx
Traws Pharma Announces New Employee Inducement Grants [Yahoo! Finance]
Medium
Report
Traws Pharma Announces New Employee Inducement Grants [Yahoo! Finance]
4/2
07:23 am
ontx
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company [Yahoo! Finance]
Low
Report
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company [Yahoo! Finance]
4/2
07:15 am
ontx
Traws Pharma Announces New Employee Inducement Grants
Low
Report
Traws Pharma Announces New Employee Inducement Grants
4/2
07:00 am
ontx
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
Low
Report
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
3/31
02:08 am
ontx
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/23
02:09 am
ontx
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/15
02:26 am
ontx
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/9
08:48 am
ontx
We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Low
Report
We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully [Yahoo! Finance]
3/8
08:12 am
ontx
Onconova Therapeutics' Rigosertib Poster Selected for AACR 2024 [Yahoo! Finance]
Low
Report
Onconova Therapeutics' Rigosertib Poster Selected for AACR 2024 [Yahoo! Finance]
3/8
08:00 am
ontx
Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
Medium
Report
Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
3/7
02:06 am
ontx
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/28
02:06 am
ontx
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/20
02:14 am
ontx
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/12
01:09 am
ontx
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/4
01:13 am
ontx
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/27
04:46 am
ontx
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.